Table 1.
Antifungals for the treatment of oropharyngeal candidiasis
| Antifungal agent | Form | Strength | Use |
|---|---|---|---|
| Topical | |||
| Nystatin | Pastille | 200,000 units | Dissolve 1-2 pastilles qid |
| Nystatin | Suspension | 100,000 units | 5 mL swish and swallow qid |
| Clotrimazole | Oral troche | 10 mg | Dissolve 1 troche 5 times/day |
| Amphotericin B | Suspension | 1 mg/mL | 1 mL swish and swallow qid |
| Amphotericin B | Lozenge | 100 mg | qid |
| Amphotericin B | Tablet | 10 mg | qid |
| Systemic | |||
| Ketoconazole | Tablet | 200 mg | 1-2 tablets qd-bid |
| Fluconazole | Tablet | 100 mg | 1 tablet qd |
| Fluconazole | Solution | 10 mg/mL | 10 ml qd |
| Itraconazole | Capsule | 100 mg | 200 mg qd |
| Itraconazole | Solution | 10 mg/mL | 10-20 ml qd-bid |
| Posaconazole | Suspension | 100 mg/2.5 mL | 100 mg qd |
Derived from data of Vazquez and Sobel (2003)
Notes: qid, four times daily; tid, three times daily; bid, twice daily; qd, once daily